Vantictumab, CAS [[1345009-45-1]]

Produktübersicht

• Artikelname: Vantictumab, CAS [[1345009-45-1]]
• Artikelnummer: TGM-T77450
• Hersteller Artikelnummer: T77450
• Alternativnummer: TGM-T77450-1MG,TGM-T77450-5MG,TGM-T77450-10MG,TGM-T77450-25MG,TGM-T77450-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: OMP18R5

Produktbeschreibung

Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.

Produkteigenschaften

• Reinheit: 97.70%
• CAS Nummer: [1345009-45-1]
• Target-Kategorie: Wnt/beta-catenin